What is Loews Corporation's earnings per share (EPS)?

Loews Corporation (L) reported diluted earnings per share of $7.97 for fiscal year 2025. This represents a 24.3% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Loews Corporation (L) Financials

L NYSE

Trailing 12 months to June 30, 2026

Revenue $18.7B +3.5% YoY

Net Income $1.7B +25.1% YoY

EPS (Diluted) $8.16 +29.5% YoY

Free Cash Flow $1.8B -42.5% YoY

Market Cap $22.8B as of Oct 26, 2026

Price / Sales 1.2x on $18.7B revenue, trailing 12 months to June 30, 2026

Price / Earnings 13.5x on $1.7B net income, trailing 12 months to June 30, 2026

Price / Book 1.2x on $19.1B equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 26, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Aug 3, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 3, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the L SEC filings page.

Loews Corporation (L) reported $18.7B in revenue over the twelve months to Jun 30, 2026, up 3.5% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI L FY2025 2026-10-24

Loews’ earnings convert into cash, but 2025’s stronger reported profit still produced less cash than FY2023.

Revenue and net income rose 16.1% and 16.2%, respectively, from FY2023 to FY2025. Operating cash flow, however, fell 16.1% as accounts receivable rose 13.7%, indicating that working capital absorbed part of the reported growth rather than converting it proportionally into cash.

FY2025 liabilities equaled 77.3% of assets while debt-to-equity was 0.5x, so the balance sheet’s leverage is broader than borrowings alone. Because liabilities grew 4.2% while equity grew 9.5% from FY2024, the financing mix moved modestly toward equity.

Capital expenditures were $579M, equal to 17.7% of operating cash flow, indicating that reinvestment did not consume most reported operating cash. That left $2.7B of free cash flow, but FY2023-to-FY2025 FCF still declined 16.2%, so the recent improvement did not restore the earlier cash level.

Financial Health Signals

Financial Health Score (4 of 6 dimensions) 41/100

Scored as: Insurers peer group

Scored against insurers for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed: here 4 of 6, with the others left out rather than counted as zero. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Loews Corporation's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Loss Ratio

Loss Ratio measures the claims an insurer paid out against the premiums it earned, so a lower ratio leaves more of every premium dollar with the company. Loews Corporation scores 18/100 on it among other insurers.

Premium Growth

n/a

Not available for Loews Corporation, so it is left out of the overall score, which averages the 4 of 6 dimensions that can be computed.

Capital

Loews Corporation funded 21.6% of its assets with shareholders' equity at the end of fiscal year 2025, holding $18.7B of equity against $86.3B of assets. Capital ranks insurers on that cushion, and Loews Corporation scores 41/100 among other insurers.

Investment Yield

n/a

Not available for Loews Corporation, so it is left out of the overall score, which averages the 4 of 6 dimensions that can be computed.

Combined Ratio

Combined Ratio puts claims and running costs together against premiums earned, and a figure under 100% means the underwriting made money before any investment income was counted. Loews Corporation scores 19/100 on it among other insurers.

Stability

Loews Corporation reported net income of $1.7B in fiscal year 2025, against $1.4B in fiscal year 2024. Stability ranks insurers on how steady net income has been across five years, and Loews Corporation scores 85/100 among other insurers.

Piotroski F-Score Partial

7/7

Loews Corporation passes 7 of 7 computable financial strength tests (2 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), all 2 leverage/liquidity signals pass, the one computable operating efficiency signal (asset turnover improving) passes.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$4.7B

YoY+3.9%

QoQ+3.9%

5Y CAGR+3.4%

10Y CAGR+3.7%

Loews Corporation generated $4.7B in revenue in Q2 2026. This represents an increase of 3.9% from the same quarter a year earlier. Against the prior quarter it is up 3.9%.

Net Income

$444.0M

YoY+13.6%

QoQ+31.8%

5Y CAGR-10.0%

10Y CAGRn/m

Loews Corporation reported $444.0M in net income in Q2 2026. This represents an increase of 13.6% from the same quarter a year earlier. Against the prior quarter it is up 31.8%.

EPS (Diluted)

$2.16

YoY+15.5%

QoQ+32.5%

5Y CAGR-5.5%

10Y CAGRn/m

Loews Corporation earned $2.16 per diluted share (EPS) in Q2 2026. This represents an increase of 15.5% from the same quarter a year earlier. Against the prior quarter it is up 32.5%.

EBITDA

Not reported for Q2 2026.

Cash & Balance Sheet

Free Cash Flow

$708.0M

YoY-18.8%

QoQn/m

5Y CAGR+17.7%

10Y CAGR+43.6%

Loews Corporation generated $708.0M in free cash flow in Q2 2026, representing cash available after capex. This represents a decrease of 18.8% from the same quarter a year earlier. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

Cash & Debt

$508.0M

YoY+13.6%

QoQ-39.7%

5Y CAGR-2.5%

10Y CAGR+3.9%

Loews Corporation held $508.0M in cash against $8.9B in long-term debt as of Q2 2026.

Dividends Per Share

$0.06

YoY0.0%

QoQ0.0%

5Y CAGR0.0%

10Y CAGR0.0%

Loews Corporation paid $0.06 per share in dividends in Q2 2026. That is unchanged from the same quarter a year earlier. It is unchanged from the prior quarter.

Shares Outstanding

204M

YoY-1.4%

QoQ-0.7%

5Y CAGR-4.5%

10Y CAGR-4.9%

Loews Corporation had 204M shares outstanding in Q2 2026. This represents a decrease of 1.4% from the same quarter a year earlier. Against the prior quarter it is down 0.7%.

Margins & Returns

Net Margin

9.4%

YoY+0.8pp

QoQ+2.0pp

5Y change-9.5pp

10Y change+11.3pp

Loews Corporation's net profit margin was 9.4% in Q2 2026, showing the share of revenue converted to profit. This is up 0.8 percentage points from the same quarter a year earlier. Against the prior quarter it is up 2.0 percentage points.

Return on Equity

2.3%

YoY+0.1pp

QoQ+0.5pp

5Y change-1.9pp

10Y change+2.7pp

Loews Corporation's quarterly ROE was 2.3% in Q2 2026: one quarter's net income over shareholder equity, not annualized. This is up 0.1 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.5 percentage points.

Gross Margin

Not reported for Q2 2026.

Operating Margin

Not reported for Q2 2026.

Capital Allocation

Share Buybacks

$154.0M

YoY-40.1%

QoQ+396.8%

5Y CAGR-5.5%

Loews Corporation spent $154.0M on share buybacks in Q2 2026, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 40.1% from the same quarter a year earlier. Against the prior quarter it is up 396.8%.

Capital Expenditures

$258.0M

YoY+92.5%

QoQ+26.5%

5Y CAGR+21.9%

10Y CAGR-8.1%

Loews Corporation invested $258.0M in capex in Q2 2026, funding long-term assets and infrastructure. This represents an increase of 92.5% from the same quarter a year earlier. Against the prior quarter it is up 26.5%.

R&D Spending

Not reported for Q2 2026.

L Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

L quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$18.7B	$18.5B+5.4%	$17.5B+10.1%	$15.9B+13.2%	$14.0B-4.2%	$14.7B+16.5%	$12.6B-15.7%	$14.9B+6.1%	$14.1B+2.4%	$13.7B+4.8%	$13.1B-2.3%	$13.4B-6.4%	$14.3B-2.0%	$14.6B+3.8%	$14.1B-0.4%	$14.1B
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$1.1B+17.2%	$923.0M+208.7%	$299.0M+10.3%	$271.0M	N/A	N/A	N/A	N/A	N/A
Interest Expense	$441.0M	$437.0M-0.9%	$441.0M+17.3%	$376.0M-0.5%	$378.0M-10.8%	$424.0M-17.7%	$515.0M-12.9%	$591.0M+3.0%	$574.0M-11.1%	$646.0M+20.5%	$536.0M+3.1%	$520.0M+4.4%	$498.0M+17.2%	$425.0M-0.2%	$426.0M-18.4%	$522.0M
Income Tax	$516.0M	$511.0M+34.5%	$380.0M-15.7%	$451.0M+102.2%	$223.0M-53.1%	$475.0Mn/m	-$173.0M-169.8%	$248.0M+93.8%	$128.0M-24.7%	$170.0M-22.7%	$220.0Mn/m	-$43.0M-109.4%	$457.0M-30.3%	$656.0M+27.9%	$513.0M-3.6%	$532.0M
Net Income	$1.7B	$1.7B+17.9%	$1.4B-1.4%	$1.4B+74.5%	$822.0M-47.4%	$1.6Bn/m	-$931.0M-199.9%	$932.0M+46.5%	$636.0M-45.4%	$1.2B+78.0%	$654.0M+151.5%	$260.0M-56.0%	$591.0M-0.7%	$595.0M+4.8%	$568.0M-46.5%	$1.1B
EPS (Basic)	N/A	$7.98+24.3%	$6.42+1.9%	$6.30+85.8%	$3.39-43.7%	$6.02n/m	-$3.32-207.8%	$3.08+54.8%	$1.99-42.5%	$3.46+79.3%	$1.93+168.1%	$0.72-53.5%	$1.55+1.3%	$1.53+6.3%	$1.44-45.0%	$2.62
EPS (Diluted)	$8.16	$7.97+24.3%	$6.41+1.9%	$6.29+86.1%	$3.38-43.7%	$6.00n/m	-$3.32-208.1%	$3.07+54.3%	$1.99-42.3%	$3.45+78.8%	$1.93+168.1%	$0.72-53.5%	$1.55+1.3%	$1.53+7.0%	$1.43-45.4%	$2.62
Diluted Shares (Avg)	N/A	209M-5.2%	221M-3.2%	228M-6.4%	243M-6.5%	260M-7.2%	280M-7.6%	303M-5.2%	320M-5.2%	338M-0.2%	338M-6.7%	363M-5.2%	383M	N/A	396M-2.3%	405M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Revenue	$4.7B+3.9%	$4.6B+1.4%	$4.7B+4.1%	$4.7B+4.6%	$4.6B+6.7%	$4.5B+6.2%	$4.5B+6.8%	$4.5B+13.8%
Interest Expense	$103.0M-3.7%	$113.0M+7.6%	$113.0M+2.7%	$112.0M-1.8%	$107.0M-6.1%	$105.0M+1.9%	$110.0M+14.6%	$114.0M+21.3%
Income Tax	$141.0M+14.6%	$109.0M-10.7%	$113.0Mn/m	$153.0M+22.4%	$123.0M+9.8%	$122.0M-15.3%	-$1.0M-100.7%	$125.0M+56.3%
Net Income	$444.0M+13.6%	$337.0M-8.9%	$402.0M+115.0%	$504.0M+25.7%	$391.0M+6.0%	$370.0M-19.0%	$187.0M-58.1%	$401.0M+58.5%
EPS (Basic)	$2.16+15.5%	$1.63-6.3%	$1.95+124.1%	$2.43+32.8%	$1.87+12.0%	$1.74-15.1%	$0.87-56.1%	$1.83+63.4%
EPS (Diluted)	$2.16+15.5%	$1.63-6.3%	$1.94+123.0%	$2.43+33.5%	$1.87+12.0%	$1.74-15.1%	$0.87-56.1%	$1.82+62.5%
Diluted Shares (Avg)	206M-1.8%	206M-3.0%	N/A	208M-5.6%	209M-5.5%	213M-4.6%	N/A	220M-2.7%

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, EBITDA.

L Balance Sheet

L quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$86.3B+5.4%	$81.9B+3.5%	$79.2B+4.8%	$75.6B-7.4%	$81.6B+1.7%	$80.2B-2.4%	$82.2B+5.0%	$78.3B-1.6%	$79.6B+3.9%	$76.6B+0.8%	$76.0B-3.0%	$78.4B-2.0%	$79.9B-0.1%	$80.0B+6.3%	$75.3B
Cash & Equivalents	$495.0M-8.5%	$541.0M+35.6%	$399.0M-25.0%	$532.0M-14.3%	$621.0M+29.9%	$478.0M+42.3%	$336.0M-17.0%	$405.0M-14.2%	$472.0M+44.3%	$327.0M-25.7%	$440.0M+20.9%	$364.0M+23.8%	$294.0M+28.9%	$228.0M+76.7%	$129.0M
Short-Term Investments	$6.0B+31.2%	$4.6B+4.8%	$4.4B-9.4%	$4.9B-0.1%	$4.9B+4.0%	$4.7B+1.0%	$4.6B+19.6%	$3.9B-16.7%	$4.6B-2.5%	$4.8B-0.9%	$4.8B-20.0%	$6.0B-11.2%	$6.8B+16.1%	$5.8B+14.3%	$5.1B
Accounts Receivable	$11.0B+4.4%	$10.5B+8.9%	$9.7B+2.7%	$9.4B+1.4%	$9.3B+18.4%	$7.8B+2.1%	$7.7B+1668.4%	$434.0M-11.1%	$488.0M	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	$349.0M+0.6%	$347.0M0.0%	$347.0M+0.3%	$346.0M-0.9%	$349.0M-55.5%	$785.0M+2.3%	$767.0M+15.3%	$665.0M+0.9%	$659.0M+90.5%	$346.0M-1.4%	$351.0M-6.1%	$374.0M+4.8%	$357.0M-13.3%	$412.0M-54.6%	$908.0M
Total Liabilities	$66.7B+4.2%	$64.0B+2.1%	$62.7B+3.8%	$60.4B-3.3%	$62.5B+2.3%	$61.1B+1.2%	$60.3B+5.9%	$56.9B+3.5%	$55.0B+3.4%	$53.2B+0.1%	$53.2B-1.0%	$53.7B-2.4%	$55.0B-0.6%	$55.3B+6.3%	$52.1B
Long-Term Debt	$8.4B-5.6%	$8.9B+12.9%	$7.9B-3.0%	$8.2B-9.1%	$9.0B-10.8%	$10.1B-12.1%	$11.5B+0.9%	$11.4B+0.9%	$11.3B+5.5%	$10.7B+12.1%	$9.5B-7.9%	$10.3B+8.5%	$9.5B+3.6%	$9.2B+3.1%	$8.9B
Total Equity	$18.7B+9.5%	$17.1B+8.7%	$15.7B+9.4%	$14.3B-19.6%	$17.8B-0.1%	$17.9B-6.6%	$19.1B+3.2%	$18.5B-3.6%	$19.2B+5.7%	$18.2B+3.4%	$17.6B-8.9%	$19.3B-0.9%	$19.5B0.0%	$19.5B+3.7%	$18.8B
Retained Earnings	$17.4B+5.6%	$16.5B+5.4%	$15.6B+4.6%	$14.9B+1.0%	$14.8B+4.4%	$14.2B-10.6%	$15.8B+0.3%	$15.8B-2.0%	$16.1B+5.9%	$15.2B+3.2%	$14.7B-5.1%	$15.5B0.0%	$15.5B+2.1%	$15.2B+2.0%	$14.9B

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Total Assets	$87.2B+3.0%	$85.7B+3.0%	$86.3B+5.4%	$85.9B+2.8%	$84.7B+4.5%	$83.1B+2.8%	$81.9B+3.5%	$83.6B+9.3%
Cash & Equivalents	$508.0M+13.6%	$843.0M+50.5%	$495.0M-8.5%	$567.0M+3.5%	$447.0M-4.9%	$560.0M+0.7%	$541.0M+35.6%	$548.0M-28.1%
Short-Term Investments	$5.6B+25.7%	$5.3B+21.1%	$6.0B+31.2%	$5.4B+2.7%	$4.5B-9.4%	$4.4B-19.2%	$4.6B+4.8%	$5.2B+32.1%
Accounts Receivable	$11.7B+3.2%	$11.0B+1.9%	$11.0B+4.4%	$10.9B+7.9%	$11.4B+10.5%	$10.8B+10.6%	$10.5B+8.9%	$10.1B+7.4%
Goodwill	$483.0M+38.4%	$348.0M+0.3%	$349.0M+0.6%	$349.0M0.0%	$349.0M+0.6%	$347.0M0.0%	$347.0M0.0%	$349.0M+0.9%
Total Liabilities	$67.2B+1.4%	$66.1B+1.5%	$66.7B+4.2%	$66.7B+2.1%	$66.3B+3.8%	$65.1B+1.9%	$64.0B+2.1%	$65.4B+6.6%
Long-Term Debt	$8.9B+12.2%	$8.9B+5.8%	$8.4B-5.6%	$8.4B-4.3%	$7.9B-7.2%	$8.4B+0.2%	$8.9B+12.9%	$8.8B+11.3%
Total Equity	$19.1B+9.1%	$18.7B+8.8%	$18.7B+9.5%	$18.3B+5.4%	$17.5B+6.9%	$17.2B+6.2%	$17.1B+8.7%	$17.4B+20.1%
Retained Earnings	$18.1B+5.4%	$17.7B+5.2%	$17.4B+5.6%	$17.7B+5.3%	$17.2B+4.8%	$16.8B+4.7%	$16.5B+5.4%	$16.8B+5.8%

Not reported in any period shown, so not listed: Current Assets, Inventory, Long-Term Investments, Current Liabilities, Non-Current Liabilities.

L Cash Flow Statement

L quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	$2.6B	$3.3B+8.4%	$3.0B-22.6%	$3.9B+17.9%	$3.3B+26.3%	$2.6B+50.3%	$1.7B+0.2%	$1.7B-58.8%	$4.2B+63.0%	$2.6B+15.0%	$2.3B-36.5%	$3.5B+18.6%	$3.0B+42.6%	$2.1B-26.5%	$2.9B-28.0%	$4.0B
Depreciation & Amortization	N/A	$607.0M+4.7%	$580.0M+8.6%	$534.0M+4.9%	$509.0M+1.2%	$503.0M-25.3%	$673.0M-25.1%	$898.0M+2.0%	$880.0M+3.0%	$854.0M+1.5%	$841.0M-11.9%	$955.0M+10.9%	$861.0M+11.2%	$774.0M+2.1%	$758.0M-9.0%	$833.0M
Stock-Based Compensation	N/A	$41.0M+5.1%	$39.0M+8.3%	$36.0M+5.9%	$34.0M+3.0%	$33.0M-10.8%	$37.0M0.0%	$37.0M+5.7%	$35.0M+6.1%	$33.0M+3.1%	$32.0M+128.6%	$14.0M+133.3%	$6.0M-14.3%	$7.0M-12.5%	$8.0M-20.0%	$10.0M
Capital Expenditures	$809.0M	$579.0M-8.4%	$632.0M-7.9%	$686.0M+3.9%	$660.0M+36.9%	$482.0M-32.1%	$710.0M-31.8%	$1.0B+4.6%	$995.0M-3.5%	$1.0B-28.9%	$1.4B-6.8%	$1.6B-43.5%	$2.8B+58.5%	$1.7B+23.6%	$1.4B+63.9%	$857.0M
Free Cash Flow	$1.8B	$2.7B+12.8%	$2.4B-25.7%	$3.2B+21.4%	$2.7B+24.0%	$2.1B+106.9%	$1.0B+47.9%	$700.0M-78.3%	$3.2B+107.0%	$1.6B+94.1%	$803.0M-59.7%	$2.0B+740.5%	$237.0M-34.2%	$360.0M-75.2%	$1.4B-53.4%	$3.1B
Investing Cash Flow	-$1.9B	-$2.8Bn/m	-$2.0Bn/m	-$2.7Bn/m	-$2.3Bn/m	-$1.2Bn/m	-$1.4Bn/m	-$671.0Mn/m	-$1.4Bn/m	-$2.7Bn/m	-$2.2B	N/A	N/A	-$3.3Bn/m	-$3.1Bn/m	-$1.9B
Financing Cash Flow	-$563.0M	-$513.0Mn/m	-$898.0Mn/m	-$1.3Bn/m	-$1.0Bn/m	-$1.3Bn/m	-$198.0Mn/m	-$1.1Bn/m	-$2.8B-1510.4%	$201.0Mn/m	-$166.0M	N/A	N/A	$1.3B+278.3%	$336.0Mn/m	-$2.1B
Dividends Paid	$52.0M	$52.0M-5.5%	$55.0M-3.5%	$57.0M-6.6%	$61.0M-6.2%	$65.0M-7.1%	$70.0M-7.9%	$76.0M-5.0%	$80.0M-4.8%	$84.0M0.0%	$84.0M-6.7%	$90.0M-5.3%	$95.0M-2.1%	$97.0M-2.0%	$99.0M-2.0%	$101.0M
Share Buybacks	$340.0M	$806.0M+32.6%	$608.0M-28.4%	$849.0M+16.5%	$729.0M-35.8%	$1.1B+23.1%	$923.0M-12.2%	$1.1B+2.4%	$1.0B+375.0%	$216.0M+61.2%	$134.0M-89.4%	$1.3B+103.4%	$622.0M+172.8%	$228.0M+7.5%	$212.0M-71.0%	$732.0M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Operating Cash Flow	$966.0M-4.0%	$72.0M-90.2%	$617.0M-34.4%	$920.0M-1.5%	$1.0B+5.7%	$736.0M+271.7%	$941.0M+97.3%	$934.0M-26.9%
Capital Expenditures	$258.0M+92.5%	$204.0M+108.2%	$191.0M+9.8%	$156.0M+11.4%	$134.0M-15.7%	$98.0M-38.4%	$174.0M-22.0%	$140.0M-14.6%
Free Cash Flow	$708.0M-18.8%	-$132.0M-120.7%	$426.0M-44.5%	$764.0M-3.8%	$872.0M+10.0%	$638.0M+1535.9%	$767.0M+202.0%	$794.0M-28.7%
Investing Cash Flow	-$1.1Bn/m	$994.0Mn/m	-$611.0M-1590.2%	-$1.2Bn/m	-$809.0Mn/m	-$204.0Mn/m	$41.0Mn/m	-$740.0Mn/m
Financing Cash Flow	-$178.0Mn/m	-$714.0Mn/m	-$79.0Mn/m	$408.0Mn/m	-$322.0Mn/m	-$520.0M-152.7%	-$976.0Mn/m	-$122.0Mn/m
Dividends Paid	$13.0M0.0%	$13.0M0.0%	$13.0M0.0%	$13.0M-7.1%	$13.0M-7.1%	$13.0M-7.1%	$13.0M-7.1%	$14.0M0.0%
Share Buybacks	$154.0M-40.1%	$31.0M-92.1%	$100.0M-71.1%	$55.0M-6.8%	$257.0M+43.6%	$394.0M+1541.7%	$346.0M+147.1%	$59.0M-49.1%

Not reported in any period shown, so not listed: Depreciation & Amortization, Stock-Based Compensation.

L Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

L quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Net Margin	9.0%+1.0pp	8.1%-0.9pp	9.0%+3.2pp	5.9%-4.8pp	10.7%+18.1pp	-7.4%-13.6pp	6.2%+1.7pp	4.5%-4.0pp	8.5%+3.5pp	5.0%+3.0pp	1.9%-2.2pp	4.1%+0.1pp	4.1%0.0pp	4.0%-3.5pp	7.5%
Return on Equity	8.9%+0.6pp	8.3%-0.8pp	9.1%+3.4pp	5.7%-3.0pp	8.8%+14.0pp	-5.2%-10.1pp	4.9%+1.4pp	3.4%-2.6pp	6.1%+2.5pp	3.6%+2.1pp	1.5%-1.6pp	3.1%0.0pp	3.1%+0.1pp	2.9%-2.7pp	5.7%
Return on Assets	1.9%+0.2pp	1.7%-0.1pp	1.8%+0.7pp	1.1%-0.8pp	1.9%+3.1pp	-1.2%-2.3pp	1.1%+0.3pp	0.8%-0.7pp	1.5%+0.6pp	0.9%+0.5pp	0.3%-0.4pp	0.8%0.0pp	0.7%0.0pp	0.7%-0.7pp	1.4%
Debt-to-Equity	0.45-0.1x	0.520.0x	0.50-0.1x	0.57+0.1x	0.50-0.1x	0.560.0x	0.600.0x	0.610.0x	0.590.0x	0.590.0x	0.540.0x	0.540.0x	0.490.0x	0.470.0x	0.47
Liabilities-to-Equity	3.57-0.2x	3.75-0.2x	3.99-0.2x	4.21+0.7x	3.50+0.1x	3.42+0.3x	3.15+0.1x	3.07+0.2x	2.87-0.1x	2.93-0.1x	3.03+0.2x	2.790.0x	2.830.0x	2.84+0.1x	2.77
Asset Turnover	0.210.0x	0.210.0x	0.200.0x	0.190.0x	0.180.0x	0.160.0x	0.180.0x	0.180.0x	0.170.0x	0.170.0x	0.180.0x	0.180.0x	0.180.0x	0.180.0x	0.19
FCF Margin	14.6%+1.0pp	13.7%-6.6pp	20.3%+1.4pp	18.9%+4.3pp	14.6%+6.4pp	8.2%+3.5pp	4.7%-18.3pp	22.9%+11.6pp	11.3%+5.2pp	6.1%-8.7pp	14.8%+13.2pp	1.7%-0.8pp	2.5%-7.8pp	10.3%-11.7pp	22.0%

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Net Margin	9.4%+0.8pp	7.4%-0.8pp	8.5%+4.4pp	10.8%+1.8pp	8.6%-0.1pp	8.2%-2.6pp	4.1%-6.4pp	9.0%+2.5pp
Return on Equity	2.3%+0.1pp	1.8%-0.3pp	2.1%+1.0pp	2.8%+0.5pp	2.2%0.0pp	2.1%-0.7pp	1.1%-1.7pp	2.3%+0.6pp
Return on Assets	0.5%+0.1pp	0.4%-0.1pp	0.5%+0.2pp	0.6%+0.1pp	0.5%0.0pp	0.4%-0.1pp	0.2%-0.3pp	0.5%+0.1pp
Debt-to-Equity	0.470.0x	0.480.0x	0.45-0.1x	0.460.0x	0.45-0.1x	0.490.0x	0.520.0x	0.510.0x
Liabilities-to-Equity	3.52-0.3x	3.53-0.3x	3.57-0.2x	3.65-0.1x	3.78-0.1x	3.79-0.2x	3.75-0.2x	3.77-0.5x
Asset Turnover	0.050.0x	0.050.0x	0.050.0x	0.050.0x	0.050.0x	0.050.0x	0.060.0x	0.050.0x
FCF Margin	15.0%-4.2pp	-2.9%-17.1pp	9.0%-7.9pp	16.4%-1.4pp	19.1%+0.6pp	14.2%+13.3pp	16.9%+10.9pp	17.8%-10.6pp

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Current Ratio.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Loews Corporation L	FY2025	$18.5B	$1.7B	9.0%	$22.8B	41/100
Markel Group Inc. MKL	FY2025	$15.5B	$2.1B	13.6%	$23.2B	47/100
Cincinnati Financial Corp CINF	FY2025	$12.6B	$2.4B	18.9%	$27.2B	60/100
W.R. Berkley Corporation WRB	FY2025	$14.7B	$1.8B	12.1%	$27.4B	63/100
CNA Financial Corporation CNA	FY2025	$15.0B	$1.3B	8.5%	$13.1B	42/100
The Hartford Insurance Group, Inc. HIG	FY2025	$28.4B	$3.8B	13.5%	$36.8B	55/100

Where Loews Corporation Ranks

Frequently Asked Questions

What is Loews Corporation's annual revenue?

Loews Corporation (L) reported $18.5B in total revenue for fiscal year 2025. This represents a 5.4% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Loews Corporation's revenue growing?

Loews Corporation (L) revenue grew by 5.4% year-over-year, from $17.5B to $18.5B in fiscal year 2025.

Is Loews Corporation profitable?

Yes, Loews Corporation (L) reported a net income of $1.7B over the trailing 12 months to June 30, 2026. In fiscal year 2025 it reported a net income of $1.7B, with a net profit margin of 9.0%.

How much debt does Loews Corporation have?

As of fiscal year 2025, Loews Corporation (L) had $495.0M in cash and equivalents against $8.4B in long-term debt.

What is Loews Corporation's net profit margin?

Loews Corporation (L) had a net profit margin of 9.0% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does Loews Corporation pay dividends?

Yes, Loews Corporation (L) paid $0.25 per share in dividends during fiscal year 2025.

What is Loews Corporation's return on equity (ROE)?

Loews Corporation (L) has a return on equity of 8.9% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Loews Corporation's free cash flow?

Loews Corporation (L) generated $2.7B in free cash flow during fiscal year 2025. This represents a 12.8% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Loews Corporation's operating cash flow?

Loews Corporation (L) generated $3.3B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Loews Corporation's total assets?

Loews Corporation (L) had $86.3B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Loews Corporation's capital expenditures?

Loews Corporation (L) invested $579.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Does Loews Corporation buy back shares?

Yes, Loews Corporation (L) spent $806.0M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Loews Corporation have outstanding?

Loews Corporation (L) had 206M shares outstanding as of fiscal year 2025.

What is Loews Corporation's debt-to-equity ratio?

Loews Corporation (L) had a debt-to-equity ratio of 0.45 as of fiscal year 2025. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.

What is Loews Corporation's liabilities-to-equity ratio?

Loews Corporation (L) had a liabilities-to-equity ratio of 3.57 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.

What is Loews Corporation's return on assets (ROA)?

Loews Corporation (L) had a return on assets of 1.9% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Loews Corporation's P/E ratio?

Loews Corporation (L) trades at 13.5x earnings, its market capitalization divided by $1.7B net income, trailing 12 months to June 30, 2026. The market capitalization is $22.8B as of Oct 26, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Loews Corporation's price-to-sales ratio?

Loews Corporation (L) trades at 1.2x sales, its market capitalization divided by $18.7B revenue, trailing 12 months to June 30, 2026. The market capitalization is $22.8B as of Oct 26, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Loews Corporation's Piotroski F-Score?

Loews Corporation (L) has a Piotroski F-Score of 7 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

How financially healthy is Loews Corporation?

Loews Corporation (L) scores 41 out of 100 on our Financial Health Score, indicating moderate standing within its insurers peer group. The score is the average of six dimensions (Loss Ratio, Premium Growth, Capital, Investment Yield, Combined Ratio, Stability), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. For Loews Corporation it averages the 4 of 6 dimensions that can be computed; the others are left out rather than counted as zero. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.